ANI Pharmaceuticals | ANIP - Loan Capital


ANI Pharmaceuticals reported $286M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
ANI Pharmaceuticals USD 286M 5.84M Mar/2026
Assertio Holdings USD 39.17M 120K Sep/2025
Aurora Cannabis CAD 33.2M 1.79M Dec/2025
Canopy Growth CAD 224.99M 1.34M Dec/2025
Eli Lilly USD 39.37B 1.5B Mar/2026
Emergent BioSolutions USD 446.5M 1.7M Dec/2023
Heron Therapeutics USD 140.64M 975K Dec/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Nektar Therapeutics USD 63.16M 44.35M Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Omeros USD 403.72M 27.2M Jun/2024
Perrigo USD 3.62B 17.5M Mar/2026
Sun Pharmaceuticals INR 3.62B 36.4M Sep/2025
Teva Pharmaceutical Industries USD 14.02B 971M Mar/2026